Genetic Predisposition to the Development of Acute Community-Acquired Pneumonia
https://doi.org/10.15360/1813-9779-2010-1-5
Abstract
Objective: to study associations of DNA polymorphism in acute community-acquired pneumonia (ACAP). Subjects and methods. The study enrolled 243 patients with ACAP; a control group included 178 healthy individuals. Genetic variability was investigated for the following candidate locuses: the ACE renin-angiotensin system gene, the CCR5 chemokine receptor gene and 4 xenobiotic detoxification genes (CYP1A1, CSTM1, GSTT1, and GSTP1). According to the earlier data on the effect of CYP1A1 alleles on predisposition to pneumonia, haplotypes were determined by 3 polymorphic sites of this gene. Results. Protective and predisposing geno- and haplotypes were described by the above loci and their combinations. Homozygotes for the deletion at the ACE locus (OR=1.8; p=0.013); GSTM1-pos-itive genotypes (OR=1.7; p=0.010) and homozygotes for 606T allele in the CYP1A1 gene (OR=1.6; p=0.020) were found to have a higher predisposition to pneumonia. A combination of the two latter genotypes (OR=1.9 at p=0.006; its frequency in the control was more than 20%) proved to be prognostically most effective. Conclusion: three polymorphic markers were identified in the CYP1A1, GSTM1, and ACE genes associated with the development and course of ACAP. Key words: gene polymorphism, xenobiotic detoxification genes, pneumonia.
About the Authors
L. Ye. SalnikovaT. V. Smelaya
V. V. Moroz
A. M., Golubev
N. Sh. Lapteva
G. G. Poroshenko
A. V. Rubanovich
References
1. Шевченко Ю. Л., Софронов Г. А., Новик А. А., Белохвостова А. С.
2. Чиж И. М, Жиляев Е. Г., Галин Л. Л., Белозеров В. В.Военно-медицинская доктрина — научная основа медицинского обеспечения Вооруженных сил. ВМЖ 1995; 316 (12): 4—13.
3. Раков А. Л., Комаревцев В. Н., Харитонов М. А., Казанцев В. А.Особенности внебольничной пневмонии у военнослужащих в период вооруженного конфликта на Северном Кавказе в 1995—1996 гг. ВМЖ 2005; 326 (7): 23—30.
4. Синопальников А. И., Миронов М. Б., Комиссаров А. Л.Оптимизация этиологической диагностики и адекватная антибактериальная терапия острых пневмоний. ВМЖ 1996; 317 (2): 30—33.
5. Суханов В. А., Пирузян Л.А. Фармакогенетические проблемы в медицине. М.: Медицина; 2009. 243.
6. Waterer G. W., Quasney M. W., Cantor R. M., Wunderink R. G.Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations. Am. J. Respir. Crit. Care Med. 2001; 163 (7): 1599—1604.
7. Waterer G. W., Wunderink R. G.Science review: Genetic variability in the systemic inflammatory response. Crit. Care 2003; 7 (4): 308—314.
8. Jonsson L. S., Jonsson B. A., Axmon A. et al.Influence of glutathione-related genes on symptoms and immunologic markers among vulcanization workers in the southern Sweden rubber industries. Int. Arch. Occup. Environ. Health 2008; 8 (7): 913—919.
9. Xue B., Wu Y., Yin Z. et al.Regulation of lipopolysaccharide-induced inammatory response by glutathione S-transferase P1 in RAW264. 7cells. FEBS Lett. 2005; 579 (19): 4081—4087.
10. Habdous M., Herbeth B., Haddy N. et al.Smoking, genetic polymorphisms of glutathione S-transferases and biological indices of inflammation and cellular adhesion in the STANISLAS study. EXCLI J. 2004; 3: 58—67.
11. Сальникова Л. Е., Смелая Т. В., Мороз В. В. и соавт.Гены детоксика-ции ксенобиотиков и их роль в развитии пневмонии. Общая реаниматология 2008; IV (6): 9—16.
12. Nadif R., Mintz M., Rivas-Fuentes S. et al.Polymorphisms in chemokine and chemokine receptor genes and the development of coal workers’ pneumoconiosis. Cytokine 2006; 33 (3): 171—178.
13. van de Garde E. M., Endeman H., Deneer V. H. et al.Angiotensin-con-verting enzyme insertion/deletion polymorphism and risk and outcome of pneumonia. Chest 2008; 133 (1): 220—225.
14. Pugin J, Auckenthaler R., Mili N. et al.Diagnosis of ventilator-associated pneumonia by bacteriological analysis of bronchoscopic and non bronchoscopic «blind» bronchoalveolar lavage fiuid. Am. Rev. Respir. Dis. 1991; 143 (5 Pt 1): 1121—1129.
15. Таким образом, использование молекулярно-гене-тических тестов расширяет возможности ранней диагностики пневмонии, позволяет разработать новые высокочувствительные и точные критерии эффективности патогенетического лечения, и, в конечном итоге, может значительно повысить эффективность специализированной помощи, снизить затраты на лечение и обследование данной категории больных.
16. Сальникова Л. Е., Фомин Д. К., Елисова Т. В. и соавт.Изучение связи цитогенетических и эпидемиологических показателей с генотипами у ликвидаторов последствий аварии на ЧАЭС. Радиационная биология. Радиоэкология 2008; 48 (3): 303—312.
17. Электронная ссылкаhttp://bioinfo.iconcologia.net
18. Kisselev P., Schunck W-H., Roots I., Schwarz D.Association ofCYP1A1polymorphisms with differential metabolic activation of 17b-estradiol and estrone. Cancer Res. 2005; 65 (7): 2972—2978.
19. Meletiadis J., Chanock S., Walsh T. J.Human pharmacogenomic variations and their implications for antifungal efficacy. Clin. Microbiol. Rev. 2006; 19 (4): 763—787.
20. Электронные ссылки:http://www.genecards.org/index.shtmlhttp://www.hapmap.org/
21. Georgiadis P., Topinka J., Stoikidou M. D. et al.Interactions betweenCYP1A1polymorphisms and exposure to environmental tobacco smoke in the modulation of lymphocyte bulky DNA adducts and chromosomal aberrations. Carcinogenesis 2005; 26 (1): 93—101.
22. Rotunno M., Yu K., Lubin J. H. et al.Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression. PLoS One 2009; 4 (5): e5652.
23. Figueroa J. D., Sakoda L. C., Graubard B. I. et al.Genetic variation in hormone metabolizing genes and risk of testicular germ cell tumors. Cancer Causes Control 2008; 19 (9): 917—929.
24. Sowers M. R., Wilson A. L., Kardia S. R. et al. CYP1A1andCYP1B1polymorphisms and their association with estradiol and estrogen metaboli-ties in women who are premenopausal and perimenopausal. Am. J. Med. 2006; 119 (9 Suppl 1): 44—51.
25. Wang S., Chanock S., Tang D. et al.Assessment of interactions between pah exposure and genetic polymorphisms on PAH-DNA adducts in African, American, Dominican and Caucasian mothers and newborns. Cancer Epidemiol. Biomarkers Prev. 2008; 17 (2): 405—413.
26. Morimoto S., Okaishi K., Onishi M. et al.Deletion allele of the angiotensin-converting enzyme gene as a risk factor for pneumonia in elderly patients. Am. J. Med. 2002; 112 (2): 89—94.
27. Harding D., Baines P. B., Brull D. et al.Severity of meningococcal disease in children and the angiotensin-converting enzyme insertion/deletion polymorphism. Am. J. Respir. Crit. Care Med. 2002; 165 (8): 1103—1106.
28. Marshall R. P., Webb S., Bellingan G. J. et al.Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 2002; 166 (5): 646—650.
Review
For citations:
Salnikova L.Ye., Smelaya T.V., Moroz V.V., Golubev A.M., Lapteva N.Sh., Poroshenko G.G., Rubanovich A.V. Genetic Predisposition to the Development of Acute Community-Acquired Pneumonia . General Reanimatology. 2010;6(1):5. (In Russ.) https://doi.org/10.15360/1813-9779-2010-1-5
Views:
1579
Email this article 